A Study of YL201 in Patients With Advanced Solid Tumors

NCT05434234 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

312

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: YL201
DRUG: YL201
DRUG: YL201 and atezolizumab

Sponsor

MediLink Therapeutics (Suzhou) Co., Ltd.